Table 4.
Results of univariate analysis of selected prognostic factors for overall survival.
| Characteristics | Number of cases | Number of deaths | 5-year overall survival | P-value (long-rank) | Hazard ratio for death (95% CI) | P-value (Cox) |
|---|---|---|---|---|---|---|
| Tobacco use | ||||||
| No | 12 | 8 | 50.0 | 0.924 | Reference | 0.924 |
| Yes | 73 | 51 | 41.1 | 1.037 (0.492–2.186) | ||
| Alcohol use | ||||||
| No | 21 | 16 | 38.1 | 0.343 | Reference | 0.345 |
| Yes | 61 | 40 | 45.9 | 0.756 (0.423–1.351) | ||
| Clinical tumor status | ||||||
| T1–T2 | 27 | 16 | 63.0 | 0.031 | Reference | 0.034 |
| T3–T4 | 61 | 46 | 32.8 | 1.858 (1.049–3.291) | ||
| Clinical nodal status | ||||||
| N0 | 41 | 24 | 53.7 | 0.020 | Reference | 0.022 |
| N+ | 47 | 38 | 31.9 | 1.819 (1.089–3.038) | ||
| Clinical TNM stage* | ||||||
| Initial (I/II) | 15 | 7 | 80.0 | 0.018 | Reference | 0.022 |
| Advanced (III/IV) | 73 | 55 | 34.2 | 2.513 (1.140–5.537) | ||
| Anatomic site | ||||||
| Oral cavity | 69 | 48 | 44.9 | 0.905 | Reference | 0.905 |
| Pharynx and larynx | 19 | 14 | 31.6 | 1.037 (0.570–1.886) | ||
| Surgical margins | ||||||
| Negative | 75 | 49 | 46.7 | 0.031 | Reference | 0.034 |
| Positive | 12 | 12 | 16.7 | 2.001 (1.054–3.799) | ||
| Extranodal extension | ||||||
| Negative (N0) | 33 | 20 | 51.5 | 0.202 | Reference | |
| No (N+) | 15 | 11 | 33.3 | 1.380 (0.660–2.882) | 0.392 | |
| Yes (N+) | 23 | 18 | 30.4 | 1.777 (0.938–3.367) | 0.078 | |
| Perineural invasion | ||||||
| No | 48 | 28 | 52.1 | 0.032 | Reference | 0.035 |
| Yes | 27 | 23 | 33.3 | 1.818 (1.043–3.169) | ||
| Vascular invasion | ||||||
| No | 52 | 32 | 48.1 | 0.088 | Reference | 0.092 |
| Yes | 19 | 16 | 36.8 | 1.681 (0.919–3.073) | ||
| C228T mutation | ||||||
| No | 82 | 42 | 16.7 | 0.003 | Reference | 0.023 |
| Yes | 6 | 6 | 52.9 | 2.708 (1.150–6.374) | ||
| C250T mutation | ||||||
| No | 70 | 40 | 48.1 | 0.606 | Reference | 0.733 |
| Yes | 18 | 8 | 53.6 | 0.893 (0.465–1.715) | ||
| C228T or C250T mutation | ||||||
| No | 64 | 45 | 46.9 | 0.445 | Reference | 0.446 |
| Yes | 24 | 17 | 29.2 | 1.243 (0.710–2.177) | ||
Clinical stage according to TNM Classification of Malignant Tumors−7th ed. Bold values indicates the statistical significance (p ≤ 0.05).